Company records / imbria.com

Imbria Pharmaceuticals

Imbria Pharmaceuticals (imbria.com): 2 changes recorded in its website history since July 2019. Homepage last checked 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

HiringBetween 21 July 2019 and 10 August 2020
Added a careers page.
Observed on the company’s website; business claims are not independently verified.
earlier archived page later archived page Link to observation
HeadlineBetween 21 July 2019 and 10 August 2020
BeforeImbria Pharmaceuticals, Inc.
AfterNew treatments to enhance or restore how cells produce energy
Observed on the company’s website; business claims are not independently verified.
earlier archived page later archived page Link to observation

First recorded website

Observed 21 July 2019

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Imbria Pharmaceuticals, Inc.

archived page Link to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

January 2026 – November 2026 · 2 captures · latest observed messagingUnlocking the Power of
Imbria Pharmaceuticals is developing novel cardiovascular therapies targeting cardiac energy metabolism to address serious cardiovascular diseases.
This wording observed 6 November 2026.
current websiteHistorical capture not publicly available
Inspect 2 captures in this group
- 12 January 2026 · Unlocking the Power of archived page
- 6 November 2026 · Unlocking the Power of current websiteHistorical capture not publicly available
September 2023 – July 2025 · 3 capturesImbria – Optimizing cellular energy to treat cardiometabolic disorders
Imbria is a clinical-stage, cardiometabolic company developing innovative cellular energy enhancing therapies for the treatment of cardiovascular disorders
This wording observed 23 July 2025.
archived page
Inspect 3 captures in this group
- 12 September 2023 · Imbria – Optimizing cellular energy to treat cardiometabolic disorders archived page
- 4 January 2024 · Imbria – Optimizing cellular energy to treat cardiometabolic disorders archived page
- 23 July 2025 · Imbria – Optimizing cellular energy to treat cardiometabolic disorders archived page
August 2020 – August 2022 · 4 capturesNew treatments to enhance or restore how cells produce energy
[av_image src='http://imbria.com/wp-content/uploads/2019/08/home_header.jpg' attachment='1155' attachment_size='full' copyright='' caption='' image_size='' styling='no-styling' align='center' font_siz
This wording observed 12 August 2022.
archived page
Inspect 4 captures in this group
- 10 August 2020 · New treatments to enhance or restore how cells produce energy archived page
- 6 December 2021 · New treatments to enhance or restore how cells produce energy archived page
- 15 January 2022 · New treatments to enhance or restore how cells produce energy archived page
- 12 August 2022 · New treatments to enhance or restore how cells produce energy archived page
Seen July 2019 · 1 captureImbria Pharmaceuticals, Inc.
This wording observed 21 July 2019.
archived page

Cite this record

StartupHistory, “Imbria Pharmaceuticals” company record, https://startuphistory.org/c/imbria.com

Machine-readable: /c/imbria.com.json. How changes are found: method.